Ken Goldman

Ken Goldman is the Intellectual Property Counsel for Cthulhu Ventures LLC and for a number of companies in which Cthulhu Ventures, CMD’s founding investor, has invested including CMD and, inter alia, Warner Babcock Institute for Green Chemistry. Over 20 years of experience managing IP issues for biotechnology and diagnostics companies. He was a former IP Director at Novartis, Dynavax, Cell Genesys, and Chiron Corporation.